WallStSmart

Alignment Healthcare LLC (ALHC)vsElevance Health Inc (ELV)

VS

Smart Verdict

WallStSmart Research — data-driven comparison

Elevance Health Inc generates 4943% more annual revenue ($199.13B vs $3.95B). ELV leads profitability with a 2.8% profit margin vs -0.0%. ELV earns a higher WallStSmart Score of 67/100 (B-).

ALHC

Hold

40

out of 100

Grade: F

Growth: 8.0Profit: 2.5Value: 5.0Quality: 6.8
Piotroski: 5/9Altman Z: 3.87

ELV

Strong Buy

67

out of 100

Grade: B-

Growth: 7.3Profit: 5.0Value: 10.0Quality: 5.0
Piotroski: 3/9
IV

Intrinsic Value Comparison

Multi-model valuation · Graham Formula

Intrinsic value data unavailable for ALHC.

ELVUndervalued (+74.9%)

Margin of Safety

+74.9%

Fair Value

$1179.36

Current Price

$296.09

$883.27 discount

UndervaluedFair: $1179.36Overvalued

Key Strengths & Concerns

Side-by-side fundamental analysis

Key Strengths

ALHC2 strengths · Avg: 10.0/10
Revenue GrowthGrowth
44.4%10/10

Revenue surging 44.4% year-over-year

Altman Z-ScoreHealth
3.8710/10

Safe zone — low bankruptcy risk

ELV4 strengths · Avg: 9.3/10
P/E RatioValuation
11.5x10/10

Attractively priced relative to earnings

Price/BookValuation
1.5x10/10

Reasonable price relative to book value

Market CapQuality
$64.08B9/10

Large-cap with strong market position

EPS GrowthGrowth
36.3%8/10

Earnings expanding 36.3% YoY

Areas to Watch

ALHC4 concerns · Avg: 3.0/10
Price/BookValuation
20.0x4/10

Trading at 20.0x book value

EPS GrowthGrowth
0.0%4/10

0.0% earnings growth

Return on EquityProfitability
-0.7%2/10

ROE of -0.7% — below average capital efficiency

Free Cash FlowQuality
$-66.63M2/10

Negative free cash flow — burning cash

ELV4 concerns · Avg: 2.8/10
Profit MarginProfitability
2.8%3/10

2.8% margin — thin

Operating MarginProfitability
1.5%3/10

Operating margin of 1.5%

Piotroski F-ScoreQuality
3/93/10

Weak financial health signals

Free Cash FlowQuality
$-209.00M2/10

Negative free cash flow — burning cash

Comparative Analysis Report

WallStSmart Research

Bull Case : ALHC

The strongest argument for ALHC centers on Revenue Growth, Altman Z-Score. Revenue growth of 44.4% demonstrates continued momentum.

Bull Case : ELV

The strongest argument for ELV centers on P/E Ratio, Price/Book, Market Cap. PEG of 1.17 suggests the stock is reasonably priced for its growth.

Bear Case : ALHC

The primary concerns for ALHC are Price/Book, EPS Growth, Return on Equity.

Bear Case : ELV

The primary concerns for ELV are Profit Margin, Operating Margin, Piotroski F-Score. Thin 2.8% margins leave little buffer for downturns.

Key Dynamics to Monitor

ALHC profiles as a hypergrowth stock while ELV is a value play — different risk/reward profiles.

ALHC carries more volatility with a beta of 1.19 — expect wider price swings.

ALHC is growing revenue faster at 44.4% — sustainability is the question.

ALHC generates stronger free cash flow (-67M), providing more financial flexibility.

Bottom Line

ELV scores higher overall (67/100 vs 40/100). Both earn "Strong Buy" and "Hold" ratings respectively — the choice depends on your investment horizon and risk tolerance.

This analysis is generated from publicly available financial data. Not financial advice.

Alignment Healthcare LLC

HEALTHCARE · HEALTHCARE PLANS · USA

Alignment Healthcare, Inc. provides a consumer-centric platform that provides personalized healthcare to seniors in the United States. The company is headquartered in Orange, California.

Elevance Health Inc

HEALTHCARE · HEALTHCARE PLANS · USA

Elevance Health Inc. is a health benefits company. The company is headquartered in Indianapolis, Indiana.

Want to dig deeper into these stocks?